GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $18,000 | 0.0% | 12,150 | +7.0% | 0.01% | -15.4% |
| Q3 2015 | $18,000 | -5.3% | 11,350 | 0.0% | 0.01% | +18.2% |
| Q2 2015 | $19,000 | 0.0% | 11,350 | -18.1% | 0.01% | 0.0% |
| Q1 2015 | $19,000 | -5.0% | 13,850 | +3.7% | 0.01% | -8.3% |
| Q4 2014 | $20,000 | -28.6% | 13,350 | 0.0% | 0.01% | -14.3% |
| Q3 2014 | $28,000 | +27.3% | 13,350 | +86.7% | 0.01% | +27.3% |
| Q2 2014 | $22,000 | +144.4% | 7,150 | +107.2% | 0.01% | +266.7% |
| Q1 2014 | $9,000 | -40.0% | 3,450 | +15.0% | 0.00% | -40.0% |
| Q4 2013 | $15,000 | +400.0% | 3,000 | +100.0% | 0.01% | +400.0% |
| Q2 2013 | $3,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |